Copyright
©The Author(s) 2019.
World J Transplant. Aug 26, 2019; 9(4): 62-80
Published online Aug 26, 2019. doi: 10.5500/wjt.v9.i4.62
Published online Aug 26, 2019. doi: 10.5500/wjt.v9.i4.62
Score | Authors | Variables included in risk score | Score grades | Outcome |
Expanded criteria donor | Port et al[58], 2002 | Donor age | SCD | Relative risk of graft failure compared to SCD |
Cerebrovascular accident as cause of death | ECD | RR>1.7 | ||
Serum creatinine> 1.5mg/dL | ||||
History of hypertension | ||||
Deceased donor score | Nyberg et al[65], 2003 | Age | 5-year graft survival | |
History of hypertension | A (0-9 points) | Grade A 82% | ||
Creatinine clearance | B (10-19 points) | Grade B 79% | ||
HLA mismatch | C (20-29 points) | Grade C 72% | ||
Cause of death | D (30-39 points) | Grade D 65% | ||
Donor risk score (DRS) | Schold et al[67], 2005 | Donor risk factors | 5-year graft survival | |
Race | I | Grade I 76.7% | ||
Age | II | Grade II 73.6% | ||
History of hypertension | III | Grade III 66.3% | ||
History of diabetes | IV | Grade IV54.8% | ||
Cause of death | V | Grade V 47.6% | ||
History of hypertension | ||||
History of diabetes | ||||
Cause of death | ||||
HLA-Dr mismatch | ||||
CMV mismatch | ||||
Cold ischemia time | ||||
DGF nomogram | Irish et al[70], 2003 | Donor risk factors | Continuous point score | Delayed graft function |
Age | ||||
Serum creatinine | ||||
History of hypertension | ||||
Cause of death | ||||
Donor after cardiac death | ||||
Recipient risk factors | ||||
Peak PRA | ||||
Race | ||||
Gender | ||||
History of diabetes mellitus | ||||
Previous transplant | ||||
Pretransplant dialysis | ||||
Pretransplant transfusions | ||||
Combined transplantation | ||||
HLA mismatch | ||||
Cold ischemia time | ||||
KDRI | Rao et al[71], 2009 | Donor risk factors | KDRI quintile | 5-year graft survival |
Age | 0.45-0.79 | 82% | ||
Race | 0.80-0.96 | 79% | ||
Height | 0.97-1.15 | NA | ||
Weight | 1.16-1.45 | NA | ||
History of hypertension | >1.45 | 63% | ||
History of diabetes | ||||
Cause of death | ||||
Serum creatinine | ||||
Hepatitis C | ||||
Donation after cardiac death | ||||
HLA-B mismatch | ||||
HLA-DR mismatch | ||||
Cold ischemia time | ||||
Double or en bloc transplant | ||||
Donor-only KDRI | OPTN[72], 2014 | Donor risk factors | 5-year graft survival | |
Age | <0.6 | 80% | ||
Race | 0.61-0.79 | 78% | ||
Height | 0.80-0.99 | 74% | ||
Weight | 1.00-1.19 | 66% | ||
History of hypertension | 1.20-1.59 | 59% | ||
History of diabetes | 1.60-1.99 | 52% | ||
Cause of death | >1.99 | 44% | ||
Serum creatinine | ||||
Hepatitis C | ||||
Donation after cardiac death |
- Citation: Salvadori M, Tsalouchos A. Histological and clinical evaluation of marginal donor kidneys before transplantation: Which is best? World J Transplant 2019; 9(4): 62-80
- URL: https://www.wjgnet.com/2220-3230/full/v9/i4/62.htm
- DOI: https://dx.doi.org/10.5500/wjt.v9.i4.62